{"entity":{"type":"insider","cik":"0001604457","url":"/insider/0001604457","json_url":"/insider/0001604457.json","name":"Walker Neal","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":20,"n_filings":10,"first":"2014-05-08","last":"2023-03-03","span_basis":"filed_date"},"name_variants":[{"name":"Walker Neal","source":"filing","n_filings":10,"first_seen":"2014-05-08","last_seen":"2023-03-03"}],"transactions":[{"id":8744212,"accession":"0001209191-23-016074","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-23-016074","line_url":"/filing/0001209191-23-016074#line-6","is_derivative":false,"issuer_cik":"0001557746","issuer_name":"Aclaris Therapeutics, Inc.","issuer_ticker":"ACRS","issuer_name_source":null,"issuer_url":"/issuer/0001557746","owner_cik":"0001604457","owner_name":"Walker Neal","owner_display_name":"Walker Neal","owner_url":"/insider/0001604457","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30240.0,"shares_display":"30,240","price_per_share":12.6346,"price_display":"12.63","price_state":"stated","total_value":382070.304,"total_display":"382,070.30","total_whole":"382,070","shares_owned_after":1273202.0,"shares_owned_after_display":"1,273,202","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-03","filed_date":"2023-03-03","scope":"insider"},{"id":8744209,"accession":"0001209191-23-016074","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-23-016074","line_url":"/filing/0001209191-23-016074#line-5","is_derivative":false,"issuer_cik":"0001557746","issuer_name":"Aclaris Therapeutics, Inc.","issuer_ticker":"ACRS","issuer_name_source":null,"issuer_url":"/issuer/0001557746","owner_cik":"0001604457","owner_name":"Walker Neal","owner_display_name":"Walker Neal","owner_url":"/insider/0001604457","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":29000.0,"shares_display":"29,000","price_per_share":12.3651,"price_display":"12.37","price_state":"stated","total_value":358587.9,"total_display":"358,587.90","total_whole":"358,588","shares_owned_after":1285188.0,"shares_owned_after_display":"1,285,188","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-02","filed_date":"2023-03-03","scope":"insider"},{"id":8070173,"accession":"0001209191-23-007032","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-23-007032","line_url":"/filing/0001209191-23-007032","is_derivative":false,"issuer_cik":"0001557746","issuer_name":"Aclaris Therapeutics, Inc.","issuer_ticker":"ACRS","issuer_name_source":null,"issuer_url":"/issuer/0001557746","owner_cik":"0001604457","owner_name":"Walker Neal","owner_display_name":"Walker Neal","owner_url":"/insider/0001604457","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":16.24955752,"price_display":"16.25","price_state":"stated","total_value":81247.7876,"total_display":"81,247.79","total_whole":"81,248","shares_owned_after":1175963.0,"shares_owned_after_display":"1,175,963","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-02","filed_date":"2023-02-03","scope":"insider","n_lines":4},{"id":8070158,"accession":"0001209191-23-007032","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-007032","line_url":"/filing/0001209191-23-007032#line-1","is_derivative":false,"issuer_cik":"0001557746","issuer_name":"Aclaris Therapeutics, Inc.","issuer_ticker":"ACRS","issuer_name_source":null,"issuer_url":"/issuer/0001557746","owner_cik":"0001604457","owner_name":"Walker Neal","owner_display_name":"Walker Neal","owner_url":"/insider/0001604457","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":16.747,"price_display":"16.75","price_state":"stated","total_value":418675.0,"total_display":"418,675.00","total_whole":"418,675","shares_owned_after":1180763.0,"shares_owned_after_display":"1,180,763","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-01","filed_date":"2023-02-03","scope":"insider"},{"id":7867375,"accession":"0001209191-23-001329","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-001329","line_url":"/filing/0001209191-23-001329#line-3","is_derivative":false,"issuer_cik":"0001557746","issuer_name":"Aclaris Therapeutics, Inc.","issuer_ticker":"ACRS","issuer_name_source":null,"issuer_url":"/issuer/0001557746","owner_cik":"0001604457","owner_name":"Walker Neal","owner_display_name":"Walker Neal","owner_url":"/insider/0001604457","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":14.8895,"price_display":"14.89","price_state":"stated","total_value":223342.5,"total_display":"223,342.50","total_whole":"223,343","shares_owned_after":1205763.0,"shares_owned_after_display":"1,205,763","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-04","filed_date":"2023-01-04","scope":"insider"},{"id":7867374,"accession":"0001209191-23-001329","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-001329","line_url":"/filing/0001209191-23-001329","is_derivative":false,"issuer_cik":"0001557746","issuer_name":"Aclaris Therapeutics, Inc.","issuer_ticker":"ACRS","issuer_name_source":null,"issuer_url":"/issuer/0001557746","owner_cik":"0001604457","owner_name":"Walker Neal","owner_display_name":"Walker Neal","owner_url":"/insider/0001604457","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":15.248530808,"price_display":"15.25","price_state":"stated","total_value":381213.2702,"total_display":"381,213.27","total_whole":"381,213","shares_owned_after":1222381.0,"shares_owned_after_display":"1,222,381","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-03","filed_date":"2023-01-04","scope":"insider","n_lines":2},{"id":6822988,"accession":"0001209191-22-025537","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-22-025537","line_url":"/filing/0001209191-22-025537#line-3","is_derivative":false,"issuer_cik":"0001557746","issuer_name":"Aclaris Therapeutics, Inc.","issuer_ticker":"ACRS","issuer_name_source":null,"issuer_url":"/issuer/0001557746","owner_cik":"0001604457","owner_name":"Walker Neal","owner_display_name":"Walker Neal","owner_url":"/insider/0001604457","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":15.1828,"price_display":"15.18","price_state":"stated","total_value":303656.0,"total_display":"303,656.00","total_whole":"303,656","shares_owned_after":1245763.0,"shares_owned_after_display":"1,245,763","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-25","filed_date":"2022-04-25","scope":"insider"},{"id":6822983,"accession":"0001209191-22-025537","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-025537","line_url":"/filing/0001209191-22-025537#line-2","is_derivative":false,"issuer_cik":"0001557746","issuer_name":"Aclaris Therapeutics, Inc.","issuer_ticker":"ACRS","issuer_name_source":null,"issuer_url":"/issuer/0001557746","owner_cik":"0001604457","owner_name":"Walker Neal","owner_display_name":"Walker Neal","owner_url":"/insider/0001604457","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":15.0439,"price_display":"15.04","price_state":"stated","total_value":376097.5,"total_display":"376,097.50","total_whole":"376,098","shares_owned_after":1265763.0,"shares_owned_after_display":"1,265,763","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-22","filed_date":"2022-04-25","scope":"insider"},{"id":6822978,"accession":"0001209191-22-025537","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-025537","line_url":"/filing/0001209191-22-025537#line-1","is_derivative":false,"issuer_cik":"0001557746","issuer_name":"Aclaris Therapeutics, Inc.","issuer_ticker":"ACRS","issuer_name_source":null,"issuer_url":"/issuer/0001557746","owner_cik":"0001604457","owner_name":"Walker Neal","owner_display_name":"Walker Neal","owner_url":"/insider/0001604457","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":15.2379,"price_display":"15.24","price_state":"stated","total_value":380947.5,"total_display":"380,947.50","total_whole":"380,948","shares_owned_after":1290763.0,"shares_owned_after_display":"1,290,763","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-21","filed_date":"2022-04-25","scope":"insider"},{"id":6623682,"accession":"0001209191-22-018516","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-018516","line_url":"/filing/0001209191-22-018516#line-1","is_derivative":false,"issuer_cik":"0001557746","issuer_name":"Aclaris Therapeutics, Inc.","issuer_ticker":"ACRS","issuer_name_source":null,"issuer_url":"/issuer/0001557746","owner_cik":"0001604457","owner_name":"Walker Neal","owner_display_name":"Walker Neal","owner_url":"/insider/0001604457","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":56303.0,"shares_display":"56,303","price_per_share":15.9147,"price_display":"15.91","price_state":"stated","total_value":896045.3541,"total_display":"896,045.35","total_whole":"896,045","shares_owned_after":1315763.0,"shares_owned_after_display":"1,315,763","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-11","filed_date":"2022-03-14","scope":"insider"},{"id":6294796,"accession":"0001209191-22-008837","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-008837","line_url":"/filing/0001209191-22-008837#line-1","is_derivative":false,"issuer_cik":"0001557746","issuer_name":"Aclaris Therapeutics, Inc.","issuer_ticker":"ACRS","issuer_name_source":null,"issuer_url":"/issuer/0001557746","owner_cik":"0001604457","owner_name":"Walker Neal","owner_display_name":"Walker Neal","owner_url":"/insider/0001604457","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3595.0,"shares_display":"3,595","price_per_share":12.6602,"price_display":"12.66","price_state":"stated","total_value":45513.419,"total_display":"45,513.42","total_whole":"45,513","shares_owned_after":1239387.0,"shares_owned_after_display":"1,239,387","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-09","filed_date":"2022-02-11","scope":"insider"},{"id":4893461,"accession":"0001209191-21-037473","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-037473","line_url":"/filing/0001209191-21-037473","is_derivative":false,"issuer_cik":"0001557746","issuer_name":"Aclaris Therapeutics, Inc.","issuer_ticker":"ACRS","issuer_name_source":null,"issuer_url":"/issuer/0001557746","owner_cik":"0001604457","owner_name":"Walker Neal","owner_display_name":"Walker Neal","owner_url":"/insider/0001604457","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":33260.0,"shares_display":"33,260","price_per_share":21.63965492784125,"price_display":"21.64","price_state":"stated","total_value":719734.9229,"total_display":"719,734.92","total_whole":"719,735","shares_owned_after":1237699.0,"shares_owned_after_display":"1,237,699","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-02","filed_date":"2021-06-02","scope":"insider","n_lines":2},{"id":5522043,"accession":"0001209191-21-028451","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-028451","line_url":"/filing/0001209191-21-028451#line-1","is_derivative":false,"issuer_cik":"0001557746","issuer_name":"Aclaris Therapeutics, Inc.","issuer_ticker":"ACRS","issuer_name_source":null,"issuer_url":"/issuer/0001557746","owner_cik":"0001604457","owner_name":"Walker Neal","owner_display_name":"Walker Neal","owner_url":"/insider/0001604457","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":26.8413,"price_display":"26.84","price_state":"stated","total_value":805239.0,"total_display":"805,239.00","total_whole":"805,239","shares_owned_after":1192427.0,"shares_owned_after_display":"1,192,427","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-22","filed_date":"2021-04-26","scope":"insider"},{"id":6357722,"accession":"0001209191-18-024272","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-024272","line_url":"/filing/0001209191-18-024272#line-1","is_derivative":false,"issuer_cik":"0001557746","issuer_name":"Aclaris Therapeutics, Inc.","issuer_ticker":"ACRS","issuer_name_source":null,"issuer_url":"/issuer/0001557746","owner_cik":"0001604457","owner_name":"Walker Neal","owner_display_name":"Walker Neal","owner_url":"/insider/0001604457","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":16.75,"price_display":"16.75","price_state":"stated","total_value":167500.0,"total_display":"167,500.00","total_whole":"167,500","shares_owned_after":897184.0,"shares_owned_after_display":"897,184","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-04-05","filed_date":"2018-04-09","scope":"insider"},{"id":7053613,"accession":"0001209191-14-032371","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-032371","line_url":"/filing/0001209191-14-032371#line-1","is_derivative":false,"issuer_cik":"0001341235","issuer_name":"Aldeyra Therapeutics, Inc.","issuer_ticker":"ALDX","issuer_name_source":null,"issuer_url":"/issuer/0001341235","owner_cik":"0001604457","owner_name":"Walker Neal","owner_display_name":"Walker Neal","owner_url":"/insider/0001604457","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6250.0,"shares_display":"6,250","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":50000.0,"total_display":"50,000.00","total_whole":"50,000","shares_owned_after":6250.0,"shares_owned_after_display":"6,250","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-05-07","filed_date":"2014-05-08","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":20,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":18,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":20},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001557746","name":"Aclaris Therapeutics, Inc.","url":"/issuer/0001557746","role":"Director, Officer (President and CEO)","n_filings":9,"first_seen":"2018-04-09","last_seen":"2023-03-03"},{"type":"issuer","type_label":"ISSUER","cik":"0001341235","name":"Aldeyra Therapeutics, Inc.","url":"/issuer/0001341235","role":"Director","n_filings":1,"first_seen":"2014-05-08","last_seen":"2014-05-08"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001604457","retrieved_at":"2026-08-24T09:32:50+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}